Regular Series Drug update From Nobel Prize to clinical practice: an update on messenger RNA-based therapies for lipid disorders Ian R. Hamilton-Craig MedicineToday July 2024 2024; 25(7): 32-37
Regular Series Cardiovascular medicine clinic Lipid-lowering therapy for older people: update on prescribing Ian R. Hamilton-Craig, Christian R Hamilton-Craig MedicineToday March 2024 2024; 25(3): 49-58
Regular Series Cardiovascular medicine clinic Lipid-lowering therapy for older people: the changing paradigm Ian R. Hamilton-Craig MedicineToday January/February 2024 2024; 25(1-2): 39-45
Regular Series Cardiovascular medicine clinic Ongoing challenges in lipid management – a retrospective in nine cases Leon A. Simons MedicineToday November 2023 2023; 24(11): 47-50
Feature Article Genetics Familial hypercholesterolaemia: improving the health of individuals and families Karen Birkenhead, Mitchell Sarkies, Samantha Sundercombe, Claire Trumble, Sanjyot Vagholkar, David R. Sullivan MedicineToday September 2023 2023; 24(9): 31-37
Feature Article Lipid disorders Familial hypercholesterolaemia – enhancing the care of patients and families Nick S.R. Lan, Jing Pang, Gerald F. Watts MedicineToday 2023; 24(8 Suppl): 4-13
In Brief Familial hypercholesterolaemia cascade screening program shown to be cost effective MedicineToday June 2023
Feature Article Cardiovascular medicine Renal artery stenosis and hypertension: when to screen and how to treat Alexandra Gallagher, George Mangos MedicineToday March 2023 2023; 24(3): 23-29
Clinical Flowchart Cardiovascular medicine Duration of anticoagulation for VTE Caroline Dix, James Mcfadyen, Huyen Tran MedicineToday July 2022 2022; 23(7): 14-20
Feature Article Cardiovascular medicine Anticoagulation – extended treatment for venous thromboembolism Caroline Dix, James Mcfadyen, Huyen Tran MedicineToday July 2022 2022; 23(7): 14-20
Regular Series Clinical case review Side effects during cholesterol management. Is statin therapy always the cause? Leon A. Simons MedicineToday December 2021 2021; 22(12): 48-49
Regular Series Drug update Two PCSK9 inhibitors now PBS-subsidised for cholesterol control Leon A. Simons MedicineToday September 2021 2021; 22(9): 59-60
Clinical Flowchart Cardiovascular medicine Suggested algorithm for cascade testing for familial hypercholesterolaemia Catherine Spinks, Gerald F. Watts, Jing Pang, Tom Brett, David R Sullivan MedicineToday July 2021 2021; 22(7): 10-20
Feature Article Cardiovascular medicine Genetic testing for familial hypercholesterolaemia: a test for the family Catherine Spinks, Gerald F. Watts, Jing Pang, Tom Brett, David R. Sullivan MedicineToday July 2021 2021; 22(7): 10-20
Regular Series Cardiometabolism clinic Reducing cardiovascular risk in type 2 diabetes: emerging therapies John Amerena MedicineToday Focus on cardiometabolic matters – 2020 2020; 21(11 Suppl): 26-28
Regular Series Drug update An update on lipid therapy with PCSK9 inhibitors Leon A. Simons MedicineToday June 2018 2018; 19(6): 57-59
Clinical Flowchart Endocrinology and metabolism An approach to initiating lipid-lowering therapy in patients with type 2 diabetes Richard O'brien MedicineToday January 2017 2017; 18(1): 22-27
Feature Article Endocrinology and metabolism Managing lipid abnormalities in type 2 diabetes Richard O'brien MedicineToday January 2017 2017; 18(1): 22-27
Regular Series Drug update Alirocumab and evolocumab: a new era in cholesterol control Leon A Simons MedicineToday October 2016 2016; 17(10): 51-53
Clinical Flowchart Genetics Suggested stratification and management allocation strategy for adults diagnosed with FH Tom Brett, Gerald Watts, Jacquie Garton-smith, Damon Bell, Alistair W Vickery, Jing Pang, Diane Arnold-reed MedicineToday August 2015 2015; 16(8): 20-26
Feature Article Genetics Familial hypercholesterolaemia: challenges in primary care Tom Brett, Gerald Watts, Jacquie Garton-smith, Damon Bell, Alistair W Vickery, Jing Pang, Diane Arnold-reed MedicineToday August 2015 2015; 16(8): 20-26
Clinical Flowchart Pharmacology and therapeutics Management of hypercholesterolaemia: high-risk individuals with elevated LDL-C, normal TG and normal HDL-C levels Ian Hamilton-craig MedicineToday January 2012 2012; 13(1): 33-42
Feature Article Pharmacology and therapeutics Update on lipid management: commonly asked questions Ian Hamilton-craig MedicineToday January 2012 2012; 13(1): 33-42
Feature Article Endocrinology and metabolism The practical value of the metabolic syndrome Namson S Lau, Nicholas R Fuller, Ian D Caterson MedicineToday December 2011 2011; 12(12): 29-34
Regular Series Dermatology clinic A case of xanthelasma palpebrarum Bruce Tate MedicineToday July 2010 2010; 11(7): 69-71
